Your browser doesn't support javascript.
loading
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.
Owen, Dwight H; Singh, Navneet; Ismaila, Nofisat; Blanchard, Elizabeth; Celano, Paul; Florez, Narjust; Jain, Dharamvir; Leighl, Natasha B; Mamdani, Hirva; Masters, Gregory; Moffitt, Pamela R; Naidoo, Jarushka; Phillips, Tanyanika; Riely, Gregory J; Robinson, Andrew G; Schenk, Erin; Schneider, Bryan J; Sequist, Lecia; Spigel, David R; Jaiyesimi, Ishmael A.
Afiliação
  • Owen DH; Ohio State University, Columbus, OH.
  • Singh N; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Ismaila N; American Society of Clinical Oncology, Alexandria, VA.
  • Blanchard E; Southcoast Centers for Cancer Care, New Bedford, MA.
  • Celano P; The Cancer Center at GBMC, Townson, MD.
  • Florez N; Dana-Farber Cancer Institute, Boston, MA.
  • Jain D; Houston Methodist Cancer Center, Houston, TX.
  • Leighl NB; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Mamdani H; Karmanos Cancer Institute/Wayne State University, Detroit, MI.
  • Masters G; Helen F. Graham Cancer Center and Research Institute, Newark, DE.
  • Moffitt PR; Alliance for Clinical Trials in Cancer, Galva, IA.
  • Naidoo J; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Phillips T; City of Hope, Duarte, CA.
  • Riely GJ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Robinson AG; Kingston General Hospital, Queen's University, Kingston, Ontario, Canada.
  • Schenk E; University of Colorado Anschutz Medical Center, Aurora, CO.
  • Schneider BJ; University of Michigan Health System, Ann Arbor, MI.
  • Sequist L; Massachusetts General Hospital, Boston, MA.
  • Spigel DR; Sarah Cannon Research Institute, Nashville, TN.
  • Jaiyesimi IA; Beaumont Health Royal Oak and Oakland University William Beaumont School of Medicine, Royal Oak, MI.
J Clin Oncol ; 41(5): e1-e9, 2023 02 10.
Article em En | MEDLINE | ID: mdl-36534935
ABSTRACT
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See Appendix 1 (online only) for disclaimers and other important information. Updates are published regularly and can be found at https//ascopubs.org/nsclc-non-da-living-guideline.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article